Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose dependent enzyme induction by oxcarbazepine?

P N Patsalos1, J M Zakrzewska, A A Elyas

  • 1Institute of Neurology, National Hospital for Nervous Diseases, London, UK.

European Journal of Clinical Pharmacology
|January 1, 1990
PubMed
Summary

Oxcarbazepine (OXC) appears to be a weaker hepatic enzyme inducer than carbamazepine (CBZ) or CBZ/phenytoin (PHT) combinations for trigeminal neuralgia patients. Enzyme induction by OXC may depend on the dosage administered.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and management of acute trigeminal neuralgia.

Revue neurologique·2024
Same author

A systematic review of screening diagnostic tools for trigeminal neuralgia.

British journal of pain·2023
Same author

A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia.

British journal of anaesthesia·2019
Same author

European Academy of Neurology guideline on trigeminal neuralgia.

European journal of neurology·2019
Same author

Adverse effects of anti-epileptics in trigeminal neuralgiform pain.

Acta neurologica Scandinavica·2018
Same author

Referrals to a facial pain service.

British dental journal·2016

Area of Science:

  • Pharmacology
  • Clinical Neurology
  • Drug Metabolism

Background:

  • Trigeminal neuralgia is a debilitating neuropathic pain condition.
  • Carbamazeine (CBZ) and phenytoin (PHT) are commonly used but can induce hepatic enzymes, affecting drug metabolism.
  • Oxcarbazepine (OXC) is an alternative antiepileptic drug with a potentially different enzyme induction profile.

Purpose of the Study:

  • To compare the hepatic enzyme induction potential of oxcarbazepine (OXC) versus carbamazepine (CBZ) or CBZ/phenytoin (PHT) in patients with idiopathic trigeminal neuralgia.
  • To assess the effect of OXC monotherapy on antipyrine pharmacokinetics.

Main Methods:

  • Pharmacokinetic study involving four patients with idiopathic trigeminal neuralgia.
  • Measurement of antipyrine half-life and clearance.

Related Experiment Videos

  • Comparison of drug metabolism parameters during CBZ or CBZ/PHT treatment and OXC monotherapy.

    • Main Results:

    • Oxcarbazepine (OXC) demonstrated less hepatic enzyme induction compared to carbamazepine (CBZ) or the CBZ/PHT combination.
    • The degree of enzyme induction by OXC appeared to be dose-dependent.

    Conclusions:

    • Oxcarbazepine (OXC) may be a preferable treatment option for trigeminal neuralgia due to its lower hepatic enzyme induction potential.
    • Further studies are warranted to confirm the dose-dependent enzyme induction of OXC.